Clinical Trial

Temporal Interference Methods for Addiction Treatment

Recruiting
View on ClinicalTrials.gov →
Summary
This clinical study is testing whether a new non-invasive brain stimulation method, called temporal interference (TI), can reduce nicotine cravings and usage in people who vape. TI delivers mild electrical currents to the scalp in a way that targets deep brain areas involved in addiction, without the need for surgery. In this randomized controlled trial, participants will be assigned to one of three groups: TI stimulation to the nucleus accumbens, TI stimulation to the anterior insula, or a placebo (sham) condition. Each participant will attend a single stimulation session after 8 hours of nicotine abstinence and will use a custom vape device that measures real-time nicotine inhalation. Craving levels will be reported during and after the session. The study aims to determine whether TI to the insula or nucleus accumbens is more effective at decreasing cravings and nicotine inhalation, and whether either is more effective than sham stimulation. For one week after the session, participants will use a smartphone app to track nicotine use and cravings. The primary hypothesis is that TI stimulation to deep brain regions will reduce both nicotine craving and actual use, immediately after stimulation and over the following week, compared to the sham condition.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-09-29; most recent amendment 2026-07-13.
Status change: Not Yet Recruiting → Recruiting 2026-02-06
Trial Details
NCT Number NCT07210268
Lead Sponsor Indiana University
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Nicotine Use Disorder, Substance Use Disorders
Enrollment 120 participants
Start Date 2026-01-22
Primary Completion 2027-02-20 (estimated)
Study Completion 2027-02-27 (estimated)
Updated on ClinicalTrials.gov 2026-07-15